These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9333595)

  • 1. [Medicamentous anti-arrhythmia therapy. Is oral adjuvant therapy with electrolytes of value?].
    Haberl R
    Herz; 1997 Jun; 22 Suppl 1():77-80. PubMed ID: 9333595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of K+ and Mg2+ in treatment of acute myocardial infarct].
    Kunert M; Scheuble L; Stolzenburg H; Gülker H
    Herz; 1997 Jun; 22 Suppl 1():63-72. PubMed ID: 9333594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Magnesium deficiency and magnesium substitution. Effect on ventricular cardiac arrhythmias of various etiology].
    Zehender M; Meinertz T; Just H
    Herz; 1997 Jun; 22 Suppl 1():56-62. PubMed ID: 9333593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnesium adjunctive therapy in atrial arrhythmias.
    Ganga HV; Noyes A; White CM; Kluger J
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1308-18. PubMed ID: 23731344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of magnesium in intensive care medicine].
    Lüderitz B; Manz M
    Z Kardiol; 1994; 83 Suppl 6():121-6. PubMed ID: 7863684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS; Zehender M; Van de Loo A; Hohnloser S; Just H
    Clin Cardiol; 1994 Apr; 17(4):197-202. PubMed ID: 8187370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of magnesium on sustained ventricular tachycardia].
    Manz M; Jung W; Lüderitz B
    Herz; 1997 Jun; 22 Suppl 1():51-5. PubMed ID: 9333592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
    Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
    Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early proarrhythmia during intravenous amiodarone treatment.
    Tomcsányi J; Merkely B; Tenczer J; Papp L; Karlócai K
    Pacing Clin Electrophysiol; 1999 Jun; 22(6 Pt 1):968-70. PubMed ID: 10392400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Magnesium: current studies--critical evaluation--consequences].
    Meinertz T
    Z Kardiol; 1996; 85 Suppl 6():147-51. PubMed ID: 9064959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-specific antiarrhythmic effects of the potassium channel activator levcromakalim against repolarization-dependent tachycardias.
    Vos MA; Gorgels AP; Lipcsei GC; De Groot SH; Leunissen JD; Wellens HJ
    J Cardiovasc Electrophysiol; 1994 Sep; 5(9):731-42. PubMed ID: 7827712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of proarrhythmic events in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis.
    Kaufman ES; Zimmermann PA; Wang T; Dennish GW; Barrell PD; Chandler ML; Greene HL;
    J Am Coll Cardiol; 2004 Sep; 44(6):1276-82. PubMed ID: 15364332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone-associated "torsade de pointes". Relevance of concomitant cardiovascular medication in a patient with atrial fibrillation and structural heart disease.
    Schrickel J; Bielik H; Yang A; Schwab JO; Shlevkov N; Schimpf R; Lüderitz B; Lewalter T
    Z Kardiol; 2003 Oct; 92(10):889-92. PubMed ID: 14579055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.
    Piccini JP; Pritchett EL; Davison BA; Cotter G; Wiener LE; Koch G; Feld G; Waldo A; van Gelder IC; Camm AJ; Kowey PR; Iwashita J; Dittrich HC
    Heart Rhythm; 2016 Sep; 13(9):1777-83. PubMed ID: 27108936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].
    Bregvadze IN; Maĭkov EB; Bil'dinov OA; Kratskina TL; Klimenko IuL; Smirnova MIu; Sokolov SF; Golitsyn SP; Rozenshtraukh LV; Chazov EI
    Kardiologiia; 2007; 47(3):48-55. PubMed ID: 17495849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Torsades de pointes ventricular tachycardia induced by mosapride and flecainide in the presence of hypokalemia.
    Ohki R; Takahashi M; Mizuno O; Fujikawa H; Mitsuhashi T; Katsuki T; Ikeda U; Shimada K
    Pacing Clin Electrophysiol; 2001 Jan; 24(1):119-21. PubMed ID: 11227957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of antiarrhythmic drug management of electrical storm.
    Kowey PR
    Can J Cardiol; 1996 Apr; 12 Suppl B():3B-8B; discussion 27B-28B. PubMed ID: 8616726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.